Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Merck to acquire Calporta Therapeutics for $576m

The transaction includes an upfront payment and contingent milestone payments. Calporta is involved in the development of selective small-molecule agonists to TRPML1 (transient receptor potential cation channel, mucolipin